Your browser doesn't support javascript.
loading
AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors.
Weng, Weining; Meng, Tao; Pu, Junyi; Ma, Linjie; Shen, Yi; Wang, Zhaohui; Pan, Rong; Wang, Mingqiao; Chen, Caiwei; Wang, Lijun; Zhang, Jianjian; Zhou, Biao; Shao, Siyuan; Qian, Yu; Liu, Shuhui; Hu, Wenhao; Meng, Xun.
Afiliação
  • Weng W; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, P.R. China.
  • Meng T; Multitude Therapeutics, Shanghai, P.R. China.
  • Pu J; MabCare Therapeutics, Shanghai, P.R. China.
  • Ma L; HySlink Therapeutics, Shanghai, P.R. China.
  • Shen Y; School of Life Sciences, Northwest University, Xi'an, Shaanxi, P.R. China.
  • Wang Z; Multitude Therapeutics, Shanghai, P.R. China.
  • Pan R; Multitude Therapeutics, Shanghai, P.R. China.
  • Wang M; Abmart Inc, Shanghai, P.R. China.
  • Chen C; Abmart Inc, Shanghai, P.R. China.
  • Wang L; Abmart Inc, Shanghai, P.R. China.
  • Zhang J; Multitude Therapeutics, Shanghai, P.R. China.
  • Zhou B; Multitude Therapeutics, Shanghai, P.R. China.
  • Shao S; Multitude Therapeutics, Shanghai, P.R. China.
  • Qian Y; Multitude Therapeutics, Shanghai, P.R. China.
  • Liu S; Shanghai OneTar Biomedicine, Shanghai, P.R. China.
  • Hu W; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, P.R. China.
  • Meng X; Multitude Therapeutics, Shanghai, P.R. China.
Mol Cancer Ther ; 22(9): 1013-1027, 2023 09 05.
Article em En | MEDLINE | ID: mdl-37302522

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoconjugados / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Imunoconjugados / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article